Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP505038.RA7_ASgR-qn5MY30OFJV5vQtAFb3TrvS0bJFsGtX-faHg130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP505038.RA7_ASgR-qn5MY30OFJV5vQtAFb3TrvS0bJFsGtX-faHg130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP505038.RA7_ASgR-qn5MY30OFJV5vQtAFb3TrvS0bJFsGtX-faHg130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP505038.RA7_ASgR-qn5MY30OFJV5vQtAFb3TrvS0bJFsGtX-faHg130_provenance.
- NP505038.RA7_ASgR-qn5MY30OFJV5vQtAFb3TrvS0bJFsGtX-faHg130_assertion description "[We found significantly higher levels of vascular endothelial growth factor (VEGF) and markedly decreased levels of placental growth factor in untreated patients with ET with respect to control subjects.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP505038.RA7_ASgR-qn5MY30OFJV5vQtAFb3TrvS0bJFsGtX-faHg130_provenance.
- NP505038.RA7_ASgR-qn5MY30OFJV5vQtAFb3TrvS0bJFsGtX-faHg130_assertion evidence source_evidence_literature NP505038.RA7_ASgR-qn5MY30OFJV5vQtAFb3TrvS0bJFsGtX-faHg130_provenance.
- NP505038.RA7_ASgR-qn5MY30OFJV5vQtAFb3TrvS0bJFsGtX-faHg130_assertion SIO_000772 20615083 NP505038.RA7_ASgR-qn5MY30OFJV5vQtAFb3TrvS0bJFsGtX-faHg130_provenance.
- NP505038.RA7_ASgR-qn5MY30OFJV5vQtAFb3TrvS0bJFsGtX-faHg130_assertion wasDerivedFrom befree-20140225 NP505038.RA7_ASgR-qn5MY30OFJV5vQtAFb3TrvS0bJFsGtX-faHg130_provenance.
- NP505038.RA7_ASgR-qn5MY30OFJV5vQtAFb3TrvS0bJFsGtX-faHg130_assertion wasGeneratedBy ECO_0000203 NP505038.RA7_ASgR-qn5MY30OFJV5vQtAFb3TrvS0bJFsGtX-faHg130_provenance.
- befree-20140225 importedOn "2014-02-25" NP505038.RA7_ASgR-qn5MY30OFJV5vQtAFb3TrvS0bJFsGtX-faHg130_provenance.